Although this molecular feature is one of the molecular characteristics of diffuse GC, the pathogenetic mechanism of the CLDN18-ARHGAP fusion gene and its potential targeted therapeutic strategies need further exploration [18]. Here, CLDN18 is linked to gastric cancer.